Metoprolol Succinate

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

52 API Suppliers, 34 USDMF, 17 CEP/COS, 13 EU WC, 17 NDC API, 26 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

3 Drugs in Development

3 Drugs in Development

INTERMEDIATES

5 Intermediates Suppliers

5 Intermediates Suppliers

FINISHED DOSAGE FORMULATIONS

185 FDF Dossiers, 95 FDA Orange Book, 30 Europe, 27 Australia, 33 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET, EXTENDED RELEASE;ORAL - EQ 100MG TARTRATE, TABLET, EXTENDED RELEASE;ORAL - EQ 200MG TARTRATE, TABLET, EXTENDED RELEASE;ORAL - EQ 25MG TARTRATE, TABLET, EXTENDED RELEASE;ORAL - EQ 50MG TARTRATE, CAPSULE, EXTENDED RELEASE;ORAL - EQ 100MG TARTRATE, CAPSULE, EXTENDED RELEASE;ORAL - EQ 200MG TARTRATE, CAPSULE, EXTENDED RELEASE;ORAL - EQ 25MG TARTRATE, CAPSULE, EXTENDED RELEASE;ORAL - EQ 50MG TARTRATE, TABLET, EXTENDED RELEASE;ORAL - 12.5MG;EQ 100MG TARTRATE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, EXTENDED RELEASE;ORAL - 12.5MG;EQ 25MG TARTRATE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, EXTENDED RELEASE;ORAL - 12.5MG;EQ 50MG TARTRATE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

1 Minakem, 3 Evonik, 2 Rochem International Inc, 6 SPI Pharma, 2 Seqens, 10 DKSH, 6 Faran Shimi Pharmaceutical, 5 Boai NKY Pharmaceuticals Ltd, 1 Chynops Pharma, 13 Gangwal Healthcare, 7 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 4 ACG Worldwide, 7 Actylis, 1 Aeon Procare, 3 Alcedo Pharmachem, 9 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 30 BASF, 1 Clariant, 15 Corel Pharma Chem, 5 DFE Pharma, 2 Finar, 12 Gangwal Chemicals, 13 Ideal Cures Pvt Ltd, 3 Ingredion Pharma Solutions, 32 Kerry, 5 Kima Chemical, 6 Lonza Capsugel, 17 Microlex e.U, 2 Nanjing Bold Chemical, 1 NEWEDGE Overseas, 2 Nomisma Healthcare, 3 Novo Excipients, 4 Pharmatrans-Sanaq, 6 Pluviaendo, 4 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 21 Roquette, 14 Seppic, 6 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 11 Sigachi Industries, 4 The Dow Chemical Company, 1 Ulanqab Kema New Material, 2 Valens Pharmachem, 4 Vasa Pharmachem, 2 Vertellus

EXCIPIENTS BY APPLICATIONS

79 Fillers, Diluents & Binders, 71 Coating Systems & Additives, 44 Controlled & Modified Release, 39 Direct Compression, 39 Thickeners and Stabilizers, 36 Solubilizers, 35 Disintegrants & Superdisintegrants, 27 Granulation, 25 Lubricants & Glidants, 22 Film Formers & Plasticizers, 18 Co-Processed Excipients, 17 Topical, 16 Taste Masking, 14 Parenteral, 12 Chewable & Orodispersible Aids, 9 Emulsifying Agents, 9 Empty Capsules, 8 Rheology Modifiers, 5 API Stability Enhancers, 5 Coloring Agents, 4 Vegetarian Capsules, 4 Surfactant & Foaming Agents

DIGITAL CONTENT

2 DATA COMPILATION #PharmaFlow, 32 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

2 US Medicaid Prescriptions, 12 Finished Drug Prices

MARKET PLACE

8 APIs, 1 FDF Dossiers

PATENTS & EXCLUSIVITIES

8 US Patents, 3 Health Canada Patents

REF. STANDARDS & IMPURITIES

2 EDQM, 1 USP, 1 Others

$ Xls

Filters

Xls

USFDA APPLICATION NUMBER - 21956 / DOSAGE - TABLET, EXTENDED RELEASE;ORAL - 12.5MG;EQ 100MG TARTRATE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Ingredient Name	Basis of Strength	Strength
Active Ingredient/Active Moiety
HYDROCHLOROTHIAZIDE(UNII: 0J48LPH2TH) (HYDROCHLOROTHIAZIDE - UNII:0J48LPH2TH)	HYDROCHLOROTHIAZIDE	12.5mg \| 12.5mg \| 12.5mg
METOPROLOL SUCCINATE(UNII: TH25PD4CCB) (METOPROLOL - UNII:GEB06NHM23)	METOPROLOL	100mg \| 50mg \| 25mg

Inactive Ingredients

Ingredient Name	AstraZeneca Pharmaceuticals LP	Concordia Pharmaceuticals Inc.	Covis Pharmaceuticals Inc	Solubiomix
CELLULOSE, MICROCRYSTALLINE(OP1R32D61U)
ETHYLCELLULOSES(7Z8S9VYZ4B)
FERRIC OXIDE RED(1K09F3G675)
FERRIC OXIDE YELLOW(EX438O2MRT)
HYDROXYPROPYL CELLULOSE (1600000 WAMW)(RFW2ET671P)
HYDROXYPROPYL CELLULOSE (TYPE H)(RFW2ET671P)
HYDROXYPROPYL CELLULOSE(RFW2ET671P)
HYPROMELLOSE, UNSPECIFIED(3NXW29V3WO)
HYPROMELLOSES(3NXW29V3WO)
PARAFFIN(I9O0E3H2ZE)
POLYETHYLENE GLYCOL 6000(30IQX730WE)
POLYETHYLENE GLYCOLS(3WJQ0SDW1A)
POVIDONE K15(E54VE15114)
SILICON DIOXIDE(ETJ7Z6XBU4)
SODIUM STEARYL FUMARATE(7CV7WJK4UI)
STARCH, CORN(O8232NY3SJ)
TITANIUM DIOXIDE(15FIX9V2JP)

Drug Product Composition: Metoprolol Succinate